Cargando…
Enhanced Vasculogenic Capacity Induced by 5-Fluorouracil Chemoresistance in a Gastric Cancer Cell Line
Chemotherapy is still widely used as a coadjutant in gastric cancer when surgery is not possible or in presence of metastasis. During tumor evolution, gatekeeper mutations provide a selective growth advantage to a subpopulation of cancer cells that become resistant to chemotherapy. When this phenome...
Autores principales: | Peri, Sara, Biagioni, Alessio, Versienti, Giampaolo, Andreucci, Elena, Staderini, Fabio, Barbato, Giuseppe, Giovannelli, Lisa, Coratti, Francesco, Schiavone, Nicola, Cianchi, Fabio, Papucci, Laura, Magnelli, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303918/ https://www.ncbi.nlm.nih.gov/pubmed/34299320 http://dx.doi.org/10.3390/ijms22147698 |
Ejemplares similares
-
5-Fluorouracil Conversion Pathway Mutations in Gastric Cancer
por: Biagioni, Alessio, et al.
Publicado: (2020) -
MAP Kinases Pathways in Gastric Cancer
por: Magnelli, Lucia, et al.
Publicado: (2020) -
Gastric Cancer Vascularization and the Contribution of Reactive Oxygen Species
por: Biagioni, Alessio, et al.
Publicado: (2023) -
An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy
por: Peri, Sara, et al.
Publicado: (2022) -
Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma
por: Lucarini, Laura, et al.
Publicado: (2017)